Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 23,399 followers.

#JITC Short Report: Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations https://t.co/aZ7JRQLi5f https://t.co/X0pVFODqte

#JITC Short Report: Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations https://t.co/aZ7JRQLi5f https://t.co/bLuP8Jso7s

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations https://t.co/hVuaRVV4FA

RT @ingentium_mel: #proteomics test for anti-PD-1 checkpoint blockade treatment of metastatic #melanoma with and without BRAF mutations. ht…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.